Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...
Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...
1d
News Medical on MSNEarly lung cancer diagnosis improved with ctDNA methylation biomarkersEarly diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...
BioSymetrics is a leading AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to ...
2d
News Medical on MSNHigh GATA6 expression predicts improved outcomes in pancreatic cancerThis new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...
The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...
“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...
Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results